Bio-Gene Technology Ltd (BGT) — Financial Flexibility Index
Bio-Gene Technology Ltd (BGT) has a Financial Flexibility Index of -3.08x as of December 2025. Free cash flow of AU$-946.60K (operating CF AU$-946.61K minus capex AU$4.00) represents -3% of total liabilities (AU$307.71K). Check Bio-Gene Technology Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Bio-Gene Technology Ltd Financial Flexibility Index (2014–2025)
Historical Financial Flexibility Index trend for Bio-Gene Technology Ltd across 11 annual periods. For the full cash flow conversion analysis, see how efficiently does Bio-Gene Technology Ltd generate cash.
Annual Financial Flexibility Index for Bio-Gene Technology Ltd (2014–2025)
Year-by-year free cash flow to debt coverage for Bio-Gene Technology Ltd. Explore Bio-Gene Technology Ltd (BGT) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (AUD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.86x | AU$-2.54 Million | AU$-2.54 Million | AU$522.98K | ▲ +34.8% |
| 2024 | -7.46x | AU$-2.75 Million | AU$-2.75 Million | AU$368.45K | ▼ -39.8% |
| 2023 | -5.34x | AU$-3.28 Million | AU$-3.28 Million | AU$613.88K | ▼ -11066.5% |
| 2022 | 0.05x | AU$50.35K | AU$43.52K | AU$1.03 Million | ▲ +102.0% |
| 2021 | -2.42x | AU$-1.82 Million | AU$-1.83 Million | AU$754.57K | ▲ +16.5% |
| 2020 | -2.89x | AU$-1.64 Million | AU$-1.64 Million | AU$567.29K | ▲ +19.2% |
| 2019 | -3.58x | AU$-2.20 Million | AU$-2.20 Million | AU$613.61K | ▼ -27.6% |
| 2018 | -2.81x | AU$-2.13 Million | AU$-2.37 Million | AU$759.59K | ▼ -45.1% |
| 2017 | -1.94x | AU$-724.17K | AU$-729.15K | AU$373.94K | ▼ -89.5% |
| 2016 | -1.02x | AU$-391.32K | AU$-419.35K | AU$383.00K | ▲ +97.9% |
| 2014 | -48.21x | AU$-46.04K | AU$-47.57K | AU$955.00 | — |